EC Number |
Inhibitors |
Structure |
---|
2.1.1.45 | (+)tetrahydropteroylglutamate |
- |
|
2.1.1.45 | (2S)-2-[(4-([(2,4-diaminopteridin-6-yl)methyl](methyl)amino)phenyl)formamido]pentanedioic acid |
i.e, methotrexate, A DHFR inhibitor, binds at the DHFR active site |
|
2.1.1.45 | (2S)-2-[([4-[(2-amino-6-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)sulfanyl]phenyl]carbonyl)amino]pentanedioic acid |
dual inhibitor of thymidylate synthase and dihydrofolate reductase. Comparison with inhibitory effect on human and Toxoplasma gondii enzyme |
|
2.1.1.45 | (2S)-2-[([4-[(2-amino-6-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)sulfanyl]phenyl]carbonyl)amino]pentanedioic acid |
dual inhibitor of thymidylate synthase and dihydrofolate reductase. Comparison with inhibitory effect on Escherichia coli and Toxoplasma gondii enzyme |
|
2.1.1.45 | (6R)-tetrahydropteroylglutamate |
- |
|
2.1.1.45 | (S)-2-(5(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid |
BW1843U89, U89, distorts the thymidylate synthase active site |
|
2.1.1.45 | (S)-2-(5(((1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9 yl)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid |
- |
|
2.1.1.45 | (S)-2-(5(((1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid |
- |
|
2.1.1.45 | (S)-2-(5-(((1,2-dihydro3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
BW1843U89 |
|
2.1.1.45 | 1,1-bis-(4-hydroxyphenyl)-1H-naphtho[1,2-c]furan-3-one |
- |
|